Blood test could predict who faces rapid kidney decline in diabetes
NCT ID NCT05198284
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a blood-based test called KidneyIntelX can help doctors better manage patients with type 2 diabetes and early-stage chronic kidney disease. The test estimates the risk of rapid kidney function decline over five years. Researchers will see if using this test leads to more patients hitting treatment targets—like blood pressure, blood sugar, and protective medications—and whether it improves kidney health. The study includes 2,000 adults with type 2 diabetes and mild to moderate kidney impairment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KidneyIntelX, a blood-based diagnostic test that estimates the risk of rapid kidney function decline in people with type 2 diabetes and chronic kidney disease.
- What this could lead to
- If effective, this test could help doctors identify high-risk patients earlier and tailor treatments to slow kidney damage, potentially preventing or delaying kidney failure.
- What could go wrong
- The trial is large but still early in assessing real-world impact. The test may not consistently change doctor decisions or improve patient outcomes, and results may vary across diverse populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Health System
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test may predict rapid kidney decline in diabetes
- Blood test could flag rapid kidney failure risk in diabetes
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test may predict kidney decline in diabetes — a large trial investigates